163 related articles for article (PubMed ID: 22865237)
1. Antidepressant use is related to larger white matter lesion volume in patients with symptomatic atherosclerotic disease: the SMART-MR study.
Grool AM; van der Graaf Y; Vincken KL; Witkamp TD; Mali WP; Geerlings MI
J Neurol; 2013 Jan; 260(1):197-206. PubMed ID: 22865237
[TBL] [Abstract][Full Text] [Related]
2. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
[TBL] [Abstract][Full Text] [Related]
3. Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.
Grool AM; Gerritsen L; Zuithoff NP; Mali WP; van der Graaf Y; Geerlings MI
Biol Psychiatry; 2013 Jan; 73(2):169-76. PubMed ID: 23079234
[TBL] [Abstract][Full Text] [Related]
4. Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study.
Grool AM; van der Graaf Y; Mali WP; Geerlings MI;
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1093-100. PubMed ID: 21459931
[TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms, symptom dimensions, and white matter lesion volume in older adults: a longitudinal study.
Kirton JW; Resnick SM; Davatzikos C; Kraut MA; Dotson VM
Am J Geriatr Psychiatry; 2014 Dec; 22(12):1469-77. PubMed ID: 24211028
[TBL] [Abstract][Full Text] [Related]
6. Mood problems increase the risk of mortality in patients with lacunar infarcts: the SMART-MR study.
Grool AM; van der Graaf Y; Mali WP; Witkamp TD; Vincken KL; Geerlings MI;
Psychosom Med; 2012 Apr; 74(3):234-40. PubMed ID: 22434917
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study.
Jochemsen HM; Geerlings MI; Grool AM; Vincken KL; Mali WP; van der Graaf Y; Muller M
J Alzheimers Dis; 2012; 29(1):39-49. PubMed ID: 22214784
[TBL] [Abstract][Full Text] [Related]
8. Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: the Second Manifestations of ARTerial disease (SMART)-Medea study.
Grool AM; van der Graaf Y; Mali WP; Witkamp TD; Vincken KL; Geerlings MI;
Psychol Med; 2012 Feb; 42(2):359-70. PubMed ID: 21835088
[TBL] [Abstract][Full Text] [Related]
9. How much do focal infarcts distort white matter lesions and global cerebral atrophy measures?
Wang X; Valdés Hernández MC; Doubal F; Chappell FM; Wardlaw JM
Cerebrovasc Dis; 2012; 34(5-6):336-42. PubMed ID: 23154746
[TBL] [Abstract][Full Text] [Related]
10. Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study.
Grool AM; van der Graaf Y; Witkamp TD; Vincken KL; Mali WP; Geerlings MI
J Aging Res; 2011; 2011():280630. PubMed ID: 22013526
[TBL] [Abstract][Full Text] [Related]
11. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study.
Appelman AP; Vincken KL; van der Graaf Y; Vlek AL; Witkamp TD; Mali WP; Geerlings MI;
Cerebrovasc Dis; 2010; 29(1):28-35. PubMed ID: 19893309
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study.
Kloppenborg RP; Nederkoorn PJ; van der Graaf Y; Geerlings MI
Atherosclerosis; 2011 Jun; 216(2):461-6. PubMed ID: 21411090
[TBL] [Abstract][Full Text] [Related]
13. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study.
Geerlings MI; Appelman AP; Vincken KL; Algra A; Witkamp TD; Mali WP; van der Graaf Y;
Atherosclerosis; 2010 May; 210(1):130-6. PubMed ID: 19945704
[TBL] [Abstract][Full Text] [Related]
14. White Matter Lesions, Carotid and Coronary Atherosclerosis in Late-Onset Depression and Healthy Controls.
Devantier TA; Nørgaard BL; Poulsen MK; Garde E; Øvrehus KA; Marwan M; Achenbach S; Dey D; Sørensen LH; Videbech P
Psychosomatics; 2016; 57(4):369-77. PubMed ID: 27036850
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor gene polymorphisms and 2-year change in hyperintense lesion volume in men.
Taylor WD; Steffens DC; Ashley-Koch A; Payne ME; MacFall JR; Potocky CF; Krishnan KR
Mol Psychiatry; 2010 Aug; 15(8):816-22. PubMed ID: 19274051
[TBL] [Abstract][Full Text] [Related]
16. White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study.
Godin O; Dufouil C; Maillard P; Delcroix N; Mazoyer B; Crivello F; Alpérovitch A; Tzourio C
Biol Psychiatry; 2008 Apr; 63(7):663-9. PubMed ID: 17977521
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study.
Kanhai DA; de Kleijn DP; Kappelle LJ; Uiterwaal CS; van der Graaf Y; Pasterkamp G; Geerlings MI; Visseren FL;
BMJ Open; 2014 Jan; 4(1):e003824. PubMed ID: 24430876
[TBL] [Abstract][Full Text] [Related]
18. Effects of statins on the progression of cerebral white matter lesion: Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study.
Mok VC; Lam WW; Fan YH; Wong A; Ng PW; Tsoi TH; Yeung V; Wong KS
J Neurol; 2009 May; 256(5):750-7. PubMed ID: 19252811
[TBL] [Abstract][Full Text] [Related]
19. Close correlation between quantitative and qualitative assessments of white matter lesions.
Valdés Hernández Mdel C; Morris Z; Dickie DA; Royle NA; Muñoz Maniega S; Aribisala BS; Bastin ME; Deary IJ; Wardlaw JM
Neuroepidemiology; 2013; 40(1):13-22. PubMed ID: 23075702
[TBL] [Abstract][Full Text] [Related]
20. Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia.
Geerlings MI; Brickman AM; Schupf N; Devanand DP; Luchsinger JA; Mayeux R; Small SA
J Alzheimers Dis; 2012; 30(1):75-82. PubMed ID: 22377782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
